Challenges Facing the Biopharmaceutical Industry. Tuesday, November 29, 2005. Challenges Facing the Biopharmaceutical Industry. Ogunmefun, MBBS, MPH. Shortage of Appropriate Human Resources. Inability to Maximize Commercial Benefits. Intellectual Property and Freedom to Operate. Any improvement in the pace of clinical trials - e.

Monday, May 17, 2010. Among the cited examples of failed companies and misguided therapies, some have erroneously listed Biovest International or by innuendo questioned the viability of their lead drug candidate BiovaxID. The number of patients projected by the NC.

Monday, November 21, 2005. What work needs to be done;. How long the work will take;. Where, after having answered all of these questions, one might obtain funding.

Mdash; Coming Soon! Towards A Safer Choice. A company that provides safe, evidence based pharmaceutical products without compromising on the quality. Our ultimate goal is to produce and distribute non-poison medicines for total customer satisfaction. We aim to build a reputation as a company that not only provides safe; evidence based pharmaceutical products but also a company that does not compromise on quality. A Malaysian Supplier and Distributor of Pharmaceutical Products. Sek 32, 40460 Bukit Rimau,.

Atherosclerosis is the main underlying pathology of cardiovascular disease, which is still a major cause of death in the Western society and results from complex interactions between gene products involved in lipoprotein metabolism, inflammation, thrombosis, and vessel-wall structure. Read more about our reserch in the research section.